Tomas Maira-Litran

Title: Innovations of Tomas Maira-Litran

Introduction

Tomas Maira-Litran is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medical science, particularly in the development of vaccines and immunological therapies. With a total of 3 patents, his work has the potential to impact public health positively.

Latest Patents

One of his latest patents is a polysaccharide vaccine for staphylococcal infections. This invention relates to compositions of a deacetylated poly N-acetylated glucosamine (dPNAG) derived from Staphylococci. The dPNAG can be isolated from natural sources or synthesized de novo. The invention also discusses the use of dPNAG as a vaccine to induce active immunity against infections caused by coagulase-negative or coagulase-positive Staphylococci, as well as other organisms carrying the ica (intracellular adhesion) locus. Additionally, the invention provides methods for using antibodies directed to dPNAG, particularly for inducing passive immunity to similar infections. Another significant patent involves a conjugation process for PNAG and a carrier protein, which describes a method for conjugating a PNAG that is less than 40% N-acetylated to a carrier protein.

Career Highlights

Throughout his career, Tomas has worked with prominent organizations such as GlaxoSmithKline Biologicals SA and The Brigham and Women's Hospital, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field.

Collaborations

Some of his notable coworkers include Ralph Leon Biemans and Pierre Duvivier. Their collective expertise has contributed to the advancement of research and development in immunology.

Conclusion

Tomas Maira-Litran's innovative work in vaccine development and immunological therapies showcases his commitment to improving public health. His patents reflect a deep understanding of complex biological processes and a dedication to finding solutions for infectious diseases.